MedPath

VERQUVO

These highlights do not include all the information needed to use VERQUVO safely and effectively. See full prescribing information for VERQUVO. VERQUVO (vericiguat) tablets, for oral useInitial U.S. Approval: 2021

Approved
Approval ID

17056d73-1b1b-4bf2-9c07-b7a9367f0d6d

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Oct 26, 2023

Manufacturers
FDA

Merck Sharp & Dohme LLC

DUNS: 118446553

Products 3

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

vericiguat

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code0006-5030
Application NumberNDA214377
Product Classification
M
Marketing Category
C73594
G
Generic Name
vericiguat
Product Specifications
Route of AdministrationORAL
Effective DateOctober 26, 2023
FDA Product Classification

INGREDIENTS (10)

CROSCARMELLOSE SODIUMInactive
Code: M28OL1HH48
Classification: IACT
MICROCRYSTALLINE CELLULOSEInactive
Code: OP1R32D61U
Classification: IACT
VERICIGUATActive
Quantity: 10 mg in 1 1
Code: LV66ADM269
Classification: ACTIB
HYPROMELLOSE 2910 (5 MPA.S)Inactive
Code: R75537T0T4
Classification: IACT
LACTOSE MONOHYDRATEInactive
Code: EWQ57Q8I5X
Classification: IACT
SODIUM LAURYL SULFATEInactive
Code: 368GB5141J
Classification: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30
Classification: IACT
TALCInactive
Code: 7SEV7J4R1U
Classification: IACT
TITANIUM DIOXIDEInactive
Code: 15FIX9V2JP
Classification: IACT
FERRIC OXIDE YELLOWInactive
Code: EX438O2MRT
Classification: IACT

vericiguat

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code0006-5028
Application NumberNDA214377
Product Classification
M
Marketing Category
C73594
G
Generic Name
vericiguat
Product Specifications
Route of AdministrationORAL
Effective DateOctober 26, 2023
FDA Product Classification

INGREDIENTS (9)

MAGNESIUM STEARATEInactive
Code: 70097M6I30
Classification: IACT
SODIUM LAURYL SULFATEInactive
Code: 368GB5141J
Classification: IACT
VERICIGUATActive
Quantity: 2.5 mg in 1 1
Code: LV66ADM269
Classification: ACTIB
MICROCRYSTALLINE CELLULOSEInactive
Code: OP1R32D61U
Classification: IACT
CROSCARMELLOSE SODIUMInactive
Code: M28OL1HH48
Classification: IACT
HYPROMELLOSE 2910 (5 MPA.S)Inactive
Code: R75537T0T4
Classification: IACT
LACTOSE MONOHYDRATEInactive
Code: EWQ57Q8I5X
Classification: IACT
TALCInactive
Code: 7SEV7J4R1U
Classification: IACT
TITANIUM DIOXIDEInactive
Code: 15FIX9V2JP
Classification: IACT

vericiguat

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code0006-5029
Application NumberNDA214377
Product Classification
M
Marketing Category
C73594
G
Generic Name
vericiguat
Product Specifications
Route of AdministrationORAL
Effective DateOctober 26, 2023
FDA Product Classification

INGREDIENTS (10)

VERICIGUATActive
Quantity: 5 mg in 1 1
Code: LV66ADM269
Classification: ACTIB
MICROCRYSTALLINE CELLULOSEInactive
Code: OP1R32D61U
Classification: IACT
CROSCARMELLOSE SODIUMInactive
Code: M28OL1HH48
Classification: IACT
LACTOSE MONOHYDRATEInactive
Code: EWQ57Q8I5X
Classification: IACT
HYPROMELLOSE 2910 (5 MPA.S)Inactive
Code: R75537T0T4
Classification: IACT
TALCInactive
Code: 7SEV7J4R1U
Classification: IACT
TITANIUM DIOXIDEInactive
Code: 15FIX9V2JP
Classification: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30
Classification: IACT
SODIUM LAURYL SULFATEInactive
Code: 368GB5141J
Classification: IACT
FERRIC OXIDE REDInactive
Code: 1K09F3G675
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.